In this Commentary article, we investigate the applications of human stem cell modelling for identifying the ways in which neurodegenerative diseases such as Alzheimer's and Parkinson's affect the brain.

This Commentary article explores the applications of pathway mining for the identification of disease targets associated with breast cancer, where there is an unmet need for treatment. The mission is to identify the best proliferation marker for guiding the choice of systemic treatments for breast cancer.

Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our March Discussion Group addressing ‘Translational Biomarkers to Guide Clinical Development of CAR T-Cells’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.

Data management for diagnostic devices is fast becoming a vital concern of the biomarkers industry. With the increased prevalence of ML and AI, this article interviews key opinion leaders from Nottingham Trent University, Apis Assay Technologies, and UCB about the future perspectives of diagnostic innovation and regulation.

Presented by Oliver Braubach, Ph.D.Head of Applications at Akoya Biosciences Inc.

In Conversation With Rea Dabelic, PhD, Senior Market Development Manager in Immunology, 10x Genomics

We sat down with the Co-director of Yale Genome Editing Centre of Yale University, Xiaojun Xing, to discuss his breakthrough cryopreservation method and his thoughts on the genome editing landscape.

Our February discussion group bought together more than 40 key opinion leaders to debate the future of spatial biology. Spatial transcriptomics, single cell resolution and tissue preparation were among the key topics raised.

Our February Omics discussion group focused on novel genome editing and how new technologies are being used to tackle the challenges of transitioning to therapeutic use.

In this commentary article, we present Dr Valerie Taly’s insights on the latest research into digital droplet PCR and the potential applications of liquid biopsy in cancer detection.

Presented by Bastiaan Bijl, Head of Business Development, Single Cell Discoveries & Jens Puschhof, Principle Investigator, German Cancer Research Center

The emergence of single-cell sequencing has opened a new field in analytical biological approaches particularly allowing to uncover cell-to-cell heterogeneity of 3D cellular models and preventing incomplete conclusions drawn from bulk cell populations